Assaying Legionella pneumophila Replication in Macrophages Pretreated with Outer Membrane Vesicles
JoVE Encyclopedia of Experiments
Microbiology
0 views • 2:30 min • August 29th, 2025
Begin with a multi-well plate containing pre-treated macrophages exposed to bacterial Legionella pneumophila outer membrane vesicles, or OMVs.
Add Legionella pneumophila at a defined bacterium-to-host cell ratio to infect the OMV-treated macrophages.
During incubation, the macrophages internalize the bacteria within membrane-bound phagosomes.
OMV pre-treatment alters macrophage signaling, inhibiting phagosome maturation.
This facilitates the formation of a Legionella-containing vacuole, which protects the bacteria and allows intracellular replication.
Add a detergent and incubate to lyse the macrophages. This releases the intracellular bacteria into the medium.
Streak the diluted lysate onto a nutrient-enriched agar plate.
During incubation, the bacteria grow and form visible colonies.
Count the colonies to determine the colony-forming units, or CFUs, representing the number of viable bacteria.
Compare the CFU counts between OMV-treated and untreated macrophages.
A higher CFU in OMV-treated compared to untreated macrophages indicates that OMVs facilitate Legionella survival within the macrophages.
To infect pre-treated or untreated THP-1 cells with wild-type L.pneumophila strain core B or murine BMDM cells with a flagella-lacking mutant of this strain without changing the medium from the cells.
Add bacteria at an MOI of 0.5 which amounts to one times 10 to the fifth L.pneumophila per well. Incubate the cultures for 24 and 48 hours respectively. To lyse the cells, add saponin at a final concentration of 0.1%and incubate the cells for five minutes.
Then streak 50 microliters of the required dilutions on BCYE agar plates and incubate the plates for three days.
Visually count the formed colonies by eye and carry out calculations according to the text protocol.
Overview
This study investigates the impact of bacterial Legionella pneumophila outer membrane vesicles (OMVs) on macrophage infection dynamics. It highlights how OMV pre-treatment alters macrophage signaling and facilitates bacterial survival.
Key Study Components
Area of Science
- Microbiology
- Immunology
- Cell Biology
Background
- Legionella pneumophila is a pathogenic bacterium that can survive within macrophages.
- Outer membrane vesicles (OMVs) are released by bacteria and can influence host cell responses.
- Understanding the interaction between OMVs and macrophages is crucial for developing therapeutic strategies.
- Phagosome maturation is a key process in macrophage defense against pathogens.
Purpose of Study
- To determine the effect of OMVs on the survival of Legionella pneumophila within macrophages.
- To assess the changes in macrophage signaling due to OMV pre-treatment.
- To evaluate the colony-forming units (CFUs) of bacteria in treated versus untreated macrophages.
Methods Used
- Pre-treated macrophages were exposed to OMVs and then infected with Legionella pneumophila.
- Phagosome maturation was monitored to assess bacterial survival.
- Colony counts were performed on nutrient-enriched agar plates to quantify viable bacteria.
- THP-1 cells and murine BMDM cells were also used for infection assays.
Main Results
- OMV pre-treatment significantly increased the CFUs of Legionella pneumophila in macrophages.
- Altered macrophage signaling was observed, indicating inhibited phagosome maturation.
- Higher bacterial survival rates were noted in OMV-treated cells compared to untreated controls.
- The study provides insights into the mechanisms of bacterial evasion of host defenses.
Conclusions
- OMVs enhance the survival of Legionella pneumophila within macrophages.
- Understanding these interactions may lead to new therapeutic approaches against Legionella infections.
- The findings highlight the importance of bacterial OMVs in modulating host immune responses.
Frequently Asked Questions
Executive Industry Relevance
This assay enables mechanistic de-risking of host-pathogen interactions by quantifying how bacterial outer membrane vesicles modulate macrophage permissiveness to intracellular pathogens. It supports target validation in infectious disease research by providing a quantitative readout of bacterial survival within physiologically relevant immune cells. The method aids preclinical model selection and informs anti-virulence strategy development by revealing how pathogen-derived factors subvert host defenses.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses about bacterial virulence factors that manipulate host cell signaling.
- Scientific Value: Clarifies pathway involvement in phagosome maturation inhibition as a mechanism of immune evasion.
- Scientific Value: Supports predictive confidence by linking OMV exposure to increased intracellular bacterial replication.
Screening & Assay Development
- Scientific Value: Prepares validated macrophage systems for screening compounds that block OMV-mediated immune modulation.
- Scientific Value: Enables assay standardization through CFU-based quantification of intracellular bacterial survival.
- Scientific Value: Supports screening readiness by providing a reproducible, quantitative readout of pathogen permissiveness.
Translational & Preclinical Research
- Scientific Value: Uses disease-relevant primary and immortalized macrophage models to assess translational biomarker alignment.
- Scientific Value: Connects early mechanistic findings to preclinical continuity by modeling a key virulence strategy.
- Scientific Value: Informs risk-adjusted advancement decisions by identifying host-directed targets that reduce bacterial survival.
Pipeline & Workflow Integration
The assay fits within the discovery continuum from target validation through lead identification to preclinical evaluation of host-targeted anti-infectives.
- Discovery Biology: Supports hypothesis testing of how bacterial factors alter host signaling to promote intracellular survival.
- Screening: Describes assay readiness via CFU quantification, enabling comparison of compound effects on bacterial replication in macrophages.
- Analytics: Highlights CFU measurements as a quantitative output for comparing conditions and assessing statistical significance.
- Translational Research: Connects method to preclinical continuity through use of THP-1 and BMDM cells modeling human and murine immune responses.
- Enterprise Reuse: Frames the method as a reusable platform for evaluating other pathogen-derived vesicles or immunomodulatory compounds.
Operational & Enterprise Impact
- Scientific Value: Provides predictive confidence in target validation by reducing mechanistic ambiguity in host-pathogen interactions.
- Operational Value: Offers standardization and reproducibility through defined MOI, incubation times, and CFU counting.
- Strategic Value: Improves go/no-go decisions by identifying compounds that block OMV-mediated immune evasion.
- Portfolio Impact: Enables risk-adjusted prioritization of host-directed therapeutics that reduce intracellular bacterial survival.
Implementation Considerations
- Requires expertise in microbiology, immunology, and cell culture techniques.
- Dependent on biosafety level 2 facilities for handling Legionella pneumophila.
- Necessitates standardized macrophage differentiation and OMV isolation protocols.
- Involves adaptation considerations when extending to other bacterial species or host cell types.
- Includes practical limitations such as variability in OMV preparation and donor macrophage responsiveness.
Biopharma FAQs
Identification of Virulence Markers of Mycobacterium abscessus for Intracellular Replication in Phagocytes
Related Videos
0 Views
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
Related Videos
0 Views
Applying Live Cell Imaging and Cryo-Electron Tomography to Resolve Spatiotemporal Features of the Legionella pneumophila Dot/Icm Secretion System
Related Videos
0 Views
Purification of Pathogen Vacuoles from Legionella-infected Phagocytes
Related Videos
0 Views
Ultracentrifugation-Based Isolation of Legionella pneumophila Outer Membrane Vesicles
Related Videos
0 Views
Flow Cytometry Analysis of Intracellular and Emergent Extracellular Listeria monocytogenes In Vitro
Related Videos
0 Views
An In Vitro Assay to Quantify the Intracellular Growth of Parasite in Macrophages
Related Videos
0 Views
Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
Related Videos
0 Views
Use of Galleria mellonella as a Model Organism to Study Legionella pneumophila Infection
Related Videos
0 Views
Bone Marrow-derived Macrophage Production
Related Videos
0 Views
Last updated: 29 August 2026